Antiviral properties of simple difunctionalized enols targeted to the HIV-1 protease.
The human immunodeficiency virus type 1 (HIV-1) protease catalyses the specific cleavage of the virion structural polyproteins p55gag and p160gag-pol and is, therefore, essential for viral maturation. We have previously reported a series of low molecular weight non-peptidic enol-based compounds that inhibit the HIV-1 protease activity in a competitive fashion (Vaillancourt et al., Bioorg. Med. Chem., 2 (1994) 343-355). Here we demonstrate that VS-215 and VS-261, two of these non-peptidic inhibitors, impair viral polyprotein maturation and exhibit antiviral activity in infected MT4 cells. The ID50 for these two compounds ranged between 24 and 50 microM whereas their TD50 ranged between 60 and 200 microM depending on the cell lines used. The calculated therapeutic index of these two inhibitors both had values of 2.5 even though they were shown to be non cytotoxic at their ID50. Their calculated permeability index ranged between 0.09 and 0.79 suggesting that these enol-based inhibitors efficiently reach the site of protease activity. These results provide new information on the therapeutic potential of this new class of protease inhibitors and emphasize the usefulness of enol chemistry in the development of anti-HIV-1 protease inhibitors.
Département de Microbiologie et d'Immunologie, Université de Montréal, Quebec, Canada.
M
M
Vaillancourt
G
G
Sauvé
E
E
Cohen
D000818:Animals; D000998:Antiviral Agents / Q000494:pharmacology* / Q000633:toxicity; D002460:Cell Line; D002522:Chlorocebus aethiops; D003432:Cross-Linking Reagents; D015683:Gene Products, gag / Q000096:biosynthesis / Q000187:drug effects; D017320:HIV Protease Inhibitors / Q000494:pharmacology* / Q000633:toxicity; D015497:HIV-1 / Q000187:drug effects*; D006801:Humans; D009570:Nitriles / Q000494:pharmacology* / Q000633:toxicity; D011498:Protein Precursors / Q000096:biosynthesis / Q000187:drug effects; D014779:Virus Replication / Q000187:drug effects; D005466:Fluorocarbons
D000998:Antiviral Agents; D003432:Cross-Linking Reagents; D015683:Gene Products, gag; D017320:HIV Protease Inhibitors; D009570:Nitriles; D011498:Protein Precursors; C097407:VS 215; C097408:VS 261; D005466:Fluorocarbons